Platelet endothelial cell adhesion molecule-1 (PECAM-1): A potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma

Oncology (Switzerland)

Volumn 53, Issue 2, 1996, Pages 127-132

  Anastassiou, Gerasimos ^a   Duensing, Stefan ^a   Steinhoff, Gustav ^b   Zorn, Ulrich ^a   Grosse, Jens ^a   Dalimann, Iris ^a   Kirchner, Hartmut ^a   Ganser, Arnold ^a   Atzpodien, Jens ^a  

^a Department of Hematology Oncology ^*  (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cell adhesion molecules; Leukocyte infiltration; Renal cell carcinoma

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD14 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LEUKOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; ENDOTHELIUM; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0029967772     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227548     Document Type: Article

References (15)

1. Yong K, Khwaja A: Leucocyte cellular adhesion molecules. Blood Rev 1990:4:211-225.
2. Stoolman LM: Adhesion molecules controlling lymphocyte migration. Cell 1989:56:907-910.
3. Osborn L: Leukocyte adhesion to endothelium in inflammation. Cell 1990;62:3-6.
4. Butcher EC: Leukocyte-endothelial cell recognition: Three steps to specificity and diversity. Cell 1991:67:1033-1036.
5. Horak ER, Leek R, Klenk N, Le Jeune S, Smith K, Stuart N, Greenall M, Stcpniewska K, Harris AL: Angiogencsis. assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet 1992:340:1120-1124.
6. Gasparini G, Harris AL: Does improved control of tumor growth require an anti-cancer therapy targeting both neoplastic and intratu-moral endothelial cells? Eur J Cancer 1994;30: 201-206.
7. Newman PJ, Bemdt MC, Gorski J. White GCH, Lyman S, Paddock C, Muller WA: PECAM-I (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene super family. Science 1990:247:1219-1222.
8. McMicheal AJ, Beverly PCL, Cobbold S, Crumpton MJ, Gills W, Gotch FM, Hogg N. Horton M, Ling N, MacLennan ICM, Mason DY, Milstein C, Spiegelhaltcr D, Waldmann SI 1: Leukocyte Typing III. White Cell Differentiation Antigens. Oxford. Oxford University Press. 1987. pp 589-590.
9. Muller WA, Ratti CM, McDonnell SL, Cohn ZA: A human endothelial cell-restricted, externally disposed plasmalcmmal protein enriched in intercellular junctions. J Exp Med 1989:170: 399-414.
10. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449-460.
11. Schimmenti LA, Yan HC, Madri JA, Albelda SM: Platelet endothelial cell adhesion molecule, PECAM-I. modulates cell migration. J Cell Physiol 1992;153:417-428.
12. Vaporciyan AA, DcLisser HM, Yan HC, Mcn-digurcn H, Thom SR, Jones ML, Ward PA, Albelda SM: Involvement of platelet-endothelial cell adhesion molcculc-1 in neutrophil recruitment in vivo. Science 1993:262:1580-1582.
13. Thoenes W, Stdrkcl ST, Rumpelt HJ: Histopa-thology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). Pathol Res Pract 1986:181:125-143.
14. Stôikel S, Keymcr R, Stcinbach F, Thoenes W: Reaction patterns of tumor infiltrating lymphocytes in different renal cell carcinomas and oncocytomas. Prog Clin Bioi Res 1992:378: 217-223.
15. Banner BF, Burnham JA, Bahnson RR, Ern-stoff MS, Auerbach HE: Immunophenotypic markers in renal cell carcinoma. Mod Pathol 1990;3:129-134.